Protalix BioTherapeutics, Inc (PLX) - NYSEMKT
  • Michael Blake Kuritz | Send Message 4 Mar

    Fabry Disease: Enzyme Replacement Therapies And How Genzyme Saved Sanofi $FOLD, $SNY, $PLX http://seekingalpha.com/p/2w728
    Reply
      • Michael Blake Kuritz | Send Message 22 Jan

        $PLX or $FOLD? #FabryDisease
        Reply
          • The Linch Scale | Send Message 18 Jan

            $PLX Protalix Bio Therapeutics: Have I Found My Next 20-Bagger? A 21-page report. http://seekingalpha.com/p/2sz2e
            Reply
              • The Linch Scale | Send Message 13 Jan

                Protalix Bio Therapeutics: Have I Found My Next 20-Bagger? $PLX, $DYAX, $FOLD http://seekingalpha.com/p/2sz2e
                Reply
                  • wilkinson99 | Send Message 21 Dec 2015

                    Premarket Top % Gainers: $UUUU $HMY $AVEO $ABGL $LTBR $CHAU $RWLK Top % Losers: $FXCM $TVIX $UVXY $DUST $PLX $DGAZ
                    Reply
                      • Lowenthal Capital Partners | Send Message 20 May 2015

                        Can Protalix BioTherapeutics Deliver? $PLX http://seekingalpha.com/a/1wf58
                        Reply
                          • Biotech Beast | Send Message 12 Feb 2015

                            $PLX below $2 is a bargain with run up into Q3 results bound to start soon.
                            Reply
                              • Dr.Dre | Send Message 12 Nov 2014

                                $PLX is a buy
                                Reply
                                  • piade | Send Message 11 Nov 2014

                                    $PLX Protalix announces earnings. ($0.09) EPS vs ($0.06) EST. Misses estimates. $2.5m vs $9.5m. Misses revenue. http://stks.co/c1Eoo
                                    Reply
                                      • Clinically Sound Investor | Send Message 28 Oct 2014

                                        Protalix Should Rise On Pivotal Near-Term Clinical Trial Catalyst And Longer-Term Better Insurance... $PLX http://seekingalpha.com/a/1jrdp
                                        Reply
                                          Company Description
                                          Protalix Biotherapeutics, Inc. engages in the development and commercialization of recombinant therapeutic proteins based on ProCellEx plant cell based expression system. It offers Taliglucerase alfa injections under the brand name Elelyso, an enzyme replacement therapy for Gaucher disease. Its... More
                                          Sector: Healthcare
                                          Industry: Biotechnology
                                          Country: United States